Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Perpignano

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|July 1, 1990
Peripheral red blood cell survival invariance during piroxicam treatment in subjects with glucose-6-phosphate dehydrogenase deficiencyG Perpignano, Q Mela, V Ruggiero, et al.
Bollettino Chimico Farmaceutico|August 1, 1984
[Erythrocyte survival in patients with G6PD deficiency during administration of suprofen]G Passiu, Q Mela, G Perpignano, et al.
Drugs Under Experimental and Clinical Research|January 1, 1990
Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiencyG Perpignano, Q Mela, V Ruggiero, et al.
Reumatismo|March 22, 2003
[Safety of lornoxicam in G-6-PDH deficiency]G Perpignano, E Cacace, C Matulli, et al.
Minerva Medica|March 7, 1972
[Plasma renin activity in parenchymal nephropathies with arterial hypertension. Diagnostic and prognostic value]G Verzetti, G Emanuelli, M Busilacchi, et al.
La Clinica Terapeutica|November 1, 1995
[RS3PE syndrome. A new rheumatic inflammatory syndrome in advanced age]E Pittau, A Bogliolo, A Tinti, et al.
Drugs|January 1, 1988
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiencyQ Mela, G Perpignano, V Ruggiero, et al.
Minerva Medica|May 7, 1984
[Familial Mediterranean fever. Description of a case observed by us]G Passiu, G Perpignano, G La Nasa, et al.
Minerva Medica|March 21, 1972
[Diagnostic and prognostic value of the determination of plasma renin activity in human arterial hypertension]G Verzetti, G Emanuelli, M Busilacchi, et al.
Minerva Medica|June 23, 1970
[On the nephrotoxicity of cephaloridine: deductions from clinical use of the substance]G Verzetti, G Pagano, M Busilacchi, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|July 1, 1990
Peripheral red blood cell survival invariance during piroxicam treatment in subjects with glucose-6-phosphate dehydrogenase deficiencyG Perpignano, Q Mela, V Ruggiero, et al.
Bollettino Chimico Farmaceutico|August 1, 1984
[Erythrocyte survival in patients with G6PD deficiency during administration of suprofen]G Passiu, Q Mela, G Perpignano, et al.
Drugs Under Experimental and Clinical Research|January 1, 1990
Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiencyG Perpignano, Q Mela, V Ruggiero, et al.
Reumatismo|March 22, 2003
[Safety of lornoxicam in G-6-PDH deficiency]G Perpignano, E Cacace, C Matulli, et al.
Minerva Medica|March 7, 1972
[Plasma renin activity in parenchymal nephropathies with arterial hypertension. Diagnostic and prognostic value]G Verzetti, G Emanuelli, M Busilacchi, et al.
La Clinica Terapeutica|November 1, 1995
[RS3PE syndrome. A new rheumatic inflammatory syndrome in advanced age]E Pittau, A Bogliolo, A Tinti, et al.
Drugs|January 1, 1988
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiencyQ Mela, G Perpignano, V Ruggiero, et al.
Minerva Medica|May 7, 1984
[Familial Mediterranean fever. Description of a case observed by us]G Passiu, G Perpignano, G La Nasa, et al.
Minerva Medica|March 21, 1972
[Diagnostic and prognostic value of the determination of plasma renin activity in human arterial hypertension]G Verzetti, G Emanuelli, M Busilacchi, et al.
Minerva Medica|June 23, 1970
[On the nephrotoxicity of cephaloridine: deductions from clinical use of the substance]G Verzetti, G Pagano, M Busilacchi, et al.
Pageof 5